Intravenous Iron: Measuring Response in Anemic Surgical Patients

Summary

20 Patients will be recruited with confirmed colorectal adenocarcinoma and anemia who are planned to undergo surgery. All patients will be treated with a single dose of 1g intravenous ferric carboxymaltose (FERINJECT). It is hypothesized that intravenous iron supplementation is efficacious at raising haemoglobin levels and reduced blood transfusion requirements.

Timeline

Start

2009-09

Primary completion

2011-01

Completion

2012-03

Drugs

Indications